Litcius/Paper detail

68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent

Xiaojiang Duan, Z. Cao, Hua Zhu, Chen Liu, Xiaojun Zhang, Jinming Zhang, Yanan Ren, Futao Liu, Xuekang Cai, Xiaoyi Guo, Zhen Xi, Martin G. Pomper, Zhi Yang, Yan Fan, Xing Yang

2021European Journal of Nuclear Medicine and Molecular Imaging35 citationsDOI

Topics & Concepts

BiodistributionUreaProstate cancerGlutamate carboxypeptidase IILigand (biochemistry)ChemistryPharmacokineticsIn vivoRadiochemistryNuclear medicineNuclear chemistryCancerIn vitroMedicineBiochemistryPharmacologyReceptorInternal medicineBiotechnologyBiologyProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsPeptidase Inhibition and Analysis
68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent | Litcius